| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Datameer | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.14M | Series II | 7/12/2019 | $40M | $138.6M | $1.00 | Citi Ventures, Kleiner Perkins, Next World Capital, Redpoint Ventures, ST Telemedia, Top Tier Capital Partners | ||||
 | DeepMap | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $100.41M | Series B | 11/1/2018 | $68M | $432.95M | $2.44 | Andreessen Horowitz, GSR Ventures, iSeed Ventures, Accel Partners, Generation Investment Management, Nvidia GPU Ventures | ||||
 | Delve | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $35.44M | Series A-1 | 7/22/2025 | $32M | $300M | $19.90 | Insight Partners | ||||
 | DexCare | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161M | Series D | 8/28/2026 | $16M | $446.46M | $2.30 | Undisclosed Investors | ||||
 | Doceree | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.11M | Series B-2 | 9/27/2023 | $7.5M | $271.1M | $104.20 | Creaegis, Eight Roads Ventures, F-Prime Capital | ||||
 | eFFECTOR Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $152.08M | Series C | 8/24/2017 | $39.1M | $197.73M | $0.51 | Pfizer Venture Investments, Alexandria Venture Investments, U.S. Venture Partners, Abingworth, Novartis Venture Fund, SR One, The Column Group, Altitude Life Science Ventures, Sectoral Asset Management, Abbvie Biotech Ventures, BioMed Ventures, Astellas Ventures | ||||
 | Electra Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $302.9M | Series C | 10/22/2025 | $184.13M | $460.97M | $10.15 | Nextech, EQT Life Sciences, Sanofi, HBM Healthcare Investments, Mubadala Capital, OrbiMed, Redmile Group, New Leaf Venture Partners, Westlake BioPartners, Cormorant Asset Management, Blue Owl Capital, RA Capital Management | ||||
 | ElectraDx | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $46.77M | Series B | 11/14/2025 | $32M | $270.54M | $7.31K | TAUNS Laboratories | ||||
 | Elligo Health Research | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $213.37M | Series E-1 | 9/23/2021 | $34.87M | $392.04M | $1.99 | Morgan Stanley Expansion Capital, Ally Bridge Group, Norwest Venture Partners, Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler, Shumway Capital, Syneos Health | ||||
 | Empowerly | Education Education Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $30M | Series B | 2/21/2024 | $15M | $113.81M | $3.80 | Conductive Ventures | ||||
 | End Game Interactive | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $55.56M | Series B | 1/28/2022 | $34.78M | $255.96M | $13.06 | Undisclosed Investors | ||||
 | Entire | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $60M | Series Seed | 2/10/2026 | $60M | $300M | $25.92 | Felicis, Madrona, M12, Basis Set Ventures, 20VC, Cherry Ventures, Picus Capital, Global Founders Capital, Gergely Orosz, Theo Browne, Jerry Yang, Olivier Pomel, Garry Tan, Harry Stebbings | ||||
 | Enya | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $2.89M | Series Seed | 1/1/2020 | $2.89M | $15.54M | $1.57 | First Rays Venture Partners, XSeed Capital, Morado Venture Partners, 2.12 Angels, AiiM Partners | ||||
 | Epic Sciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $606.66M | Series A-3 | 12/29/2023 | $20.9M | $94.14M | $3.00 | Undisclosed Investors | ||||
 | Fairmarkit | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $79.11M | Series C | 9/1/2022 | $35.63M | $267.11M | $5.92 | OMERS Growth Equity, GGV Capital, Insight Partners, HighlandX, ServiceNow | ||||
 | Fevo | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106.23M | Series C-1 | 12/12/2022 | $16.59M | $296.68M | $1.15 | Undisclosed Investors | ||||
 | FINESSE | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $56.38M | Series A-1 | 7/1/2023 | $40M | $300.43M | $17.12 | TQ Ventures, Cherry Ventures, MaC Venture Capital, Hoxton Ventures, Mango Capital | ||||
 | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $12.89M | Series A-2 | 8/4/2026 | $6M | $26.38M | $1.81 | Undisclosed Investors | |||||
 | Fragment | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $55.65M | Series A-1 | 10/28/2026 | $45M | $292.7M | $24.46 | -- | ||||
 | Freshpaint | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $41.85M | Series B | 7/16/2024 | $30.7M | $234.85M | $8.47 | Threshold Ventures, SignalFire, Intel Capital, Zero Prime Ventures, Y Combinator | ||||
 | Gallatin | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65M | Series A-1 | 10/8/2026 | $44.66M | $266.67M | $1.62 | Silent Ventures, 8VC | ||||
 | Geneoscopy | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $163.58M | Series C | 1/8/2025 | $79.05M | $447.85M | $4.13 | Bio-Rad Laboratories, Petrichor, Labcorp, Morningside Ventures, Lightchain Capital, NT Investments, Granger Management, Mercy Health, Tri Locum Partners | ||||
 | Great Expectations | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.18M | Series B | 2/10/2022 | $40M | $349.63M | $16.35 | Tiger Global, Index Ventures, CRV, Root Ventures | ||||
 | GroundTruth | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $121.24M | Series F | 7/24/2018 | $18M | $477.43M | $0.35 | Eminence Capital | ||||